Abstracts tagged "Sjogren’s syndrome and sialoadenitis"

Abstract Number: 1239 • 2014 ACR/ARHP Annual Meeting
Is Lymphocytic Sialadenitis IgG4-Related?
Nathalie Shehwaro¹, Murielle Hourseau², Thomas Papo³ and Karim Sacre⁴, ¹Internal Medicine, University Paris-7, APHP, Bichat Hospital, Paris, France, ²Pathology, University Paris-7, APHP, Bichat Hospital, Paris, France, ³Internal Medicine, Bichat Hospital, Paris, Paris, France, ⁴Internal Medicine, University Paris-7, INSERM U699, APHP, Bichat Hospital, Paris, France
Background/Purpose: To assess the prevalence of IgG4-related disease among patients with lymphocytic sialadenitis on labial salivary gland biopsy. Methods: All labial salivary gland biopsies (LSGB)…
Abstract Number: 531 • 2014 ACR/ARHP Annual Meeting
Expression of Indoleamine 2,3 Dioxygenase-1 and -2 in Focal Sialoadenitis of Patients with Sjögren’s Syndrome
Claudio Vitali¹, Antonina Prafioriti², Domenico Sambataro³, Andrea Di Bernardo², Elisabetta Admiraglio², Saba Nayar⁴, Francesca Barone⁴ and Nicoletta Del Papa³, ¹Rheumatology Section, Istituto San Giuseppe, Como, Italy, ²Pathology Unit, Istituto G.Pini, Milan, Italy, ³Rheumatology Unit, Istituto G.Pini, Milan, Italy, ⁴Rheumatology Research Group, University of Birmingham Research Laboratories, University of Birmingham, Birmingham, United Kingdom
Background/Purpose The role of indoleamine 2,3 dioxygenase 1 and 2 (IDO1-IDO2) enzymes in modulating the immune response has not been so far completely clarified. IDO1…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].